RALY and cancer: At the mechanism level, RALY mainly plays a role in promoting cancer by regulating the three core methods of target gene alternative splicing, post-translational modifications (PTMs) of itself (ubiquitination, glycosylation, etc.), and mediating tumor metabolic reprogramming, thereby driving malignant biological behaviors such as tumor cell proliferation, invasion, metastasis, and chemotherapy resistance.